Archive · 13 Nov 2025
Fortis Healthcare Stock Sees 19% Upside Potential Despite Recent Decline
Imagine a company called Fortis Healthcare that runs hospitals and testing centers.
Recently, its stock price has been going down a bit, like a toy car that wobbled a little.
But, some smart people who study companies, called analysts from Choice, think Fortis is still doing a great job.
They looked at how much money the company made and found it made more than before, especially from its hospitals.
They also liked how the company is focusing on special medical treatments.
Because of this good news, the analysts think the company's stock price will go up in the future, even though it dipped recently.
They even increased the price they think the stock will reach.
Fortis Healthcare shares dropped up to 1.5% to Rs 954.25 on Thursday, continuing a recent downward trend.
Despite recent weakness, Choice Institutional Equities reiterated a 'Buy' call and raised the target price to Rs 1,140, projecting a 19% upside.
The brokerage's optimism is based on Fortis' Q2FY26 performance, which showed significant year-over-year growth in revenue, EBITDA, and adjusted PAT.
The hospital business, representing 85% of revenue, drove growth, with notable increases in oncology and robotic surgeries.
Fortis aims to increase hospital EBITDA margins to 25% in two years through expansion and adding beds annually.
- Who
- Fortis Healthcare and Choice Institutional Equities
- What
- Fortis Healthcare's stock has declined recently, but Choice Institutional Equities maintains a positive outlook, raising its target price based on strong Q2FY26 financial performance.
- When
- Thursday's trade (for the stock price decline), Q2FY26 (for financial performance)
- Where
- Indian stock market
- Why
- The stock's decline is attributed to short-term market pressure, while the analyst's optimism is based on strong financial metrics and future growth potential, including expansion and focus on high-acuity specialities.
Analyst Optimism
Market Sentiment
Price Target
Analyst Optimism
Choice Institutional Equities maintains a 'Buy' call with an increased target price of Rs 1,140, indicating a 19% upside potential.
Market Sentiment
The stock has experienced a recent decline, losing over 6% in four sessions and falling on nine of the last eleven trading days.
Performance Outlook
Analyst Optimism
Choice highlights strong Q2FY26 performance with significant YoY growth in revenue, EBITDA, and adjusted PAT, driven by robust hospital and diagnostics segments.
Market Sentiment
The stock's recent trading pattern suggests short-term pressure and investor caution despite positive fundamental performance.
- Company
- Fortis Healthcare
- Analyst Firm
- Choice Institutional Equities
- Previous Target Price
- Rs 1,000
- Revised Target Price
- Rs 1,140
- Upside Potential
- 19%
- Q2FY26 Revenue Growth
- 17.3% YoY
- Q2FY26 EBITDA Growth
- 27.9% YoY
- Hospital Segment Revenue Growth
- 19.3% YoY